Found: 22
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3833, doi. 10.1002/cncr.33739
- Publication type:
- Article
First person profile: Patricia M. LoRusso, DO: This researcher and clinician has conducted work in early‐phase trials that has led to the approval of several anticancer agents, all while keeping her focus on the patients she says make these trials possible
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3840, doi. 10.1002/cncr.35121
- By:
- Publication type:
- Article
FDA approves new combined treatment for advanced prostate cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3841, doi. 10.1002/cncr.35122
- Publication type:
- Article
Researchers identify two new subtypes of HPV‐associated head and neck cancers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3842, doi. 10.1002/cncr.35123
- Publication type:
- Article
Top advances of the year: Pancreatic cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3843, doi. 10.1002/cncr.35031
- By:
- Publication type:
- Article
Progress in precision pediatric surgical oncology.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3852, doi. 10.1002/cncr.35073
- By:
- Publication type:
- Article
Incidence, risk factors, and management of alpelisib‐associated hyperglycemia in metastatic breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3854, doi. 10.1002/cncr.34928
- By:
- Publication type:
- Article
Persistence of patient‐detected breast cancer over time: 1990–2019.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3862, doi. 10.1002/cncr.34973
- By:
- Publication type:
- Article
Low TP53 variant allele frequency as a biomarker for anti‐programmed death (ligand) 1 monotherapy in lung adenocarcinoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3873, doi. 10.1002/cncr.34967
- By:
- Publication type:
- Article
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3884, doi. 10.1002/cncr.34982
- By:
- Publication type:
- Article
Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3894, doi. 10.1002/cncr.34947
- By:
- Publication type:
- Article
A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
- By:
- Publication type:
- Article
Accounting for Medicaid expansion and regional policy and programs to advance equity in cancer prevention in the United States.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3915, doi. 10.1002/cncr.34956
- By:
- Publication type:
- Article
Diabetic severity and oncological outcomes of colorectal cancer following curative resection: A population‐based cohort study in Taiwan.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3928, doi. 10.1002/cncr.34975
- By:
- Publication type:
- Article
Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3938, doi. 10.1002/cncr.34972
- By:
- Publication type:
- Article
Ototoxicity associated with high‐dose carboplatin for patients with previously treated germ cell tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3952, doi. 10.1002/cncr.34991
- By:
- Publication type:
- Article
Fluorescent‐guided surgery and the use of indocyanine green sentinel lymph node mapping in the pediatric and young adult oncology population.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3962, doi. 10.1002/cncr.35023
- By:
- Publication type:
- Article
A PI3K gene expression signature predicts for recurrence in early‐stage non–small cell lung cancer treated with stereotactic body radiation therapy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3971, doi. 10.1002/cncr.34983
- By:
- Publication type:
- Article
Expert consensus‐based guidance on approaches to opioid management in individuals with advanced cancer‐related pain and nonmedical stimulant use.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3978, doi. 10.1002/cncr.34921
- By:
- Publication type:
- Article
Erratum to "JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3987, doi. 10.1002/cncr.35064
- Publication type:
- Article
Retraction: Yanjing Wu, Shupeng Liu, Hong Xin, Jing Jiang, Edward Younglai, Shuhan Sun, and Huilan Wang. Up‐regulation of microRNA‐145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. Cancer 2011;117:3989‐3998
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3988, doi. 10.1002/cncr.35092
- Publication type:
- Article
Thank You to Reviewers 2023.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3989, doi. 10.1002/cncr.35046
- Publication type:
- Article